CN113046287A - Construction method and application of PHA synthase N-terminal deletion mutant - Google Patents
Construction method and application of PHA synthase N-terminal deletion mutant Download PDFInfo
- Publication number
- CN113046287A CN113046287A CN202110307034.5A CN202110307034A CN113046287A CN 113046287 A CN113046287 A CN 113046287A CN 202110307034 A CN202110307034 A CN 202110307034A CN 113046287 A CN113046287 A CN 113046287A
- Authority
- CN
- China
- Prior art keywords
- pha
- pha synthase
- phac
- synthase
- recombinant plasmid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108010010718 poly(3-hydroxyalkanoic acid) synthase Proteins 0.000 title claims abstract description 39
- 238000012217 deletion Methods 0.000 title claims abstract description 23
- 230000037430 deletion Effects 0.000 title claims abstract description 23
- 238000010276 construction Methods 0.000 title abstract description 7
- 239000013612 plasmid Substances 0.000 claims abstract description 25
- 238000000034 method Methods 0.000 claims abstract description 17
- 241000607528 Aeromonas hydrophila Species 0.000 claims abstract description 12
- 108090000790 Enzymes Proteins 0.000 claims abstract description 10
- 102000004190 Enzymes Human genes 0.000 claims abstract description 10
- 241000894006 Bacteria Species 0.000 claims abstract description 8
- 239000013604 expression vector Substances 0.000 claims abstract description 7
- 238000001976 enzyme digestion Methods 0.000 claims abstract description 6
- 230000001580 bacterial effect Effects 0.000 claims description 9
- 238000012258 culturing Methods 0.000 claims description 9
- 238000012408 PCR amplification Methods 0.000 claims description 4
- 230000003321 amplification Effects 0.000 claims description 4
- 238000005520 cutting process Methods 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 4
- 241000588724 Escherichia coli Species 0.000 claims description 3
- 238000000137 annealing Methods 0.000 claims description 3
- 238000006243 chemical reaction Methods 0.000 claims description 3
- 238000004925 denaturation Methods 0.000 claims description 3
- 230000036425 denaturation Effects 0.000 claims description 3
- 238000012257 pre-denaturation Methods 0.000 claims description 3
- 238000003892 spreading Methods 0.000 claims description 3
- 230000007480 spreading Effects 0.000 claims description 3
- 238000012216 screening Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 8
- 241000252867 Cupriavidus metallidurans Species 0.000 abstract description 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract description 6
- 229910052799 carbon Inorganic materials 0.000 abstract description 6
- 230000035772 mutation Effects 0.000 abstract description 5
- 108090000623 proteins and genes Proteins 0.000 abstract description 5
- 238000010367 cloning Methods 0.000 abstract description 3
- 230000001737 promoting effect Effects 0.000 abstract description 2
- 238000012163 sequencing technique Methods 0.000 abstract description 2
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 238000000855 fermentation Methods 0.000 abstract 1
- 230000004151 fermentation Effects 0.000 abstract 1
- 229920000903 polyhydroxyalkanoate Polymers 0.000 description 24
- 208000037534 Progressive hemifacial atrophy Diseases 0.000 description 23
- 238000012017 passive hemagglutination assay Methods 0.000 description 23
- 239000005014 poly(hydroxyalkanoate) Substances 0.000 description 21
- 239000000758 substrate Substances 0.000 description 7
- 238000001962 electrophoresis Methods 0.000 description 6
- 239000000203 mixture Substances 0.000 description 5
- 230000029087 digestion Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 101150048611 phaC gene Proteins 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 238000000246 agarose gel electrophoresis Methods 0.000 description 3
- 230000003197 catalytic effect Effects 0.000 description 3
- 239000000178 monomer Substances 0.000 description 3
- VOFUROIFQGPCGE-UHFFFAOYSA-N nile red Chemical compound C1=CC=C2C3=NC4=CC=C(N(CC)CC)C=C4OC3=CC(=O)C2=C1 VOFUROIFQGPCGE-UHFFFAOYSA-N 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 230000008859 change Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 239000013613 expression plasmid Substances 0.000 description 2
- 239000007850 fluorescent dye Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 241000588986 Alcaligenes Species 0.000 description 1
- 235000010585 Ammi visnaga Nutrition 0.000 description 1
- 244000153158 Ammi visnaga Species 0.000 description 1
- 229920001081 Commodity plastic Polymers 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000006065 biodegradation reaction Methods 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000003501 co-culture Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1025—Acyltransferases (2.3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/62—Carboxylic acid esters
- C12P7/625—Polyesters of hydroxy carboxylic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention relates to the field of molecular biology, in particular to a method for constructing an N-terminal deletion mutant of PHA synthase. Cloning Aeromonas hydrophila PHA synthase by designing a primer, and then constructing a recombinant plasmid of deletion mutation of amino acids 2 to 28 at the N end. After enzyme digestion sequencing confirms that the construction of the expression vector is successful, the expression vector is transformed into Alcaligenes eutrophus (Ralstonia eutropha) mutant strain PHB‑4Different carbon sources are selected for shake flask fermentation to verify the PHA synthase function activity, and then the PHA synthase function activity is compared with that of wild aeromonas hydrophila. Through the method, the synthase gene with the mutation at the N end has the function of generating PHA, the PHA yield is higher than that of wild bacteria, and the PHA yield is improved. This will be used in the future by gene engineering technologyThe construction of the chimeric enzyme for producing the novel PHA provides a theoretical basis and has certain value in promoting wider application of the PHA.
Description
Technical Field
The invention relates to the field of molecular biology, in particular to a method for constructing an N-terminal deletion mutant of PHA synthase.
Technical Field
Polyhydroxyalkanoate (polyhydroxyakanonate) is a substance synthesized by many bacteria under conditions of nutrient imbalance for intracellular energy and carbon source storage. PHA has good biocompatibility, biodegradability, hydrophobicity and unique properties brought by different functional groups, is used as a tissue engineering material drug sustained-release material, and is a biological material with good development potential. Water-insoluble high molecular weight PHAs exhibit thermoplastic and/or elastomeric properties, as well as other physical and material properties, including biodegradation, biocompatibility, piezoelectricity, etc., and have attracted increasing attention from the industry. PHAs have many potential uses, such as bulk commodity plastics, fishing lines, woven materials, and potential biomedical applications.
The existing PHA production has the problems of high production cost, low yield and single component. PHA synthase is a key enzyme in the synthesis of PHA, and its activity and substrate specificity determine the content and composition of PHA. In the study of deletion mutation of PHA synthase, it was found that the N-terminus of PHA synthase is related to the properties of the enzyme, such as substrate specificity, enzyme activity, heat resistance, and plays an important role in the composition of the final polymer for polymerization. The research aims to change the substrate specificity of PHA synthase, improve the catalytic activity of PHA synthase and improve the PHA yield by modifying the N end.
Alcaligenes eutropha (r. eutropha) PHA synthase has very high enzymatic activity but produces only PHB. The Aeromonas hydrophila WQ (A. hydrophila WQ) PHA synthase has a wide substrate range and produces P (3HB-co-3HHx), but its PHA-producing ability is low. Based on these two parents, engineering the N-terminus of PHA synthase to produce novel PHAs is of great theoretical and practical interest.
Disclosure of Invention
The invention aims to research the deletion mutation of the N end of the synthase gene, research the influence of the N end on the synthase property, change the substrate specificity of PHA synthase, improve the catalytic activity of PHA synthase, improve the PHA yield and facilitate the construction of PHA mosaic enzyme in the future.
In order to achieve the purpose, the invention adopts the technical scheme that: a method for constructing a PHA synthase N-terminal deletion mutation by cloning and designing primers comprises the following steps: a method for constructing an N-terminal deletion mutant of PHA synthase comprises the following steps:
1) obtaining a sequence of aeromonas hydrophila WQ (A.hydrophila WQ) from NCBI, and designing primers P1 and P2 according to the sequence;
P1-5’-TTAAAGCTTCTAATGGAGCGCACCGCCCAG-3’P2-5’-TTTGAATTCTCATGCGGCGTCCTCCTCT-3’
2) in the form of pUC19-phaPCJWQUsing P1 and P2 as primers as a template, and obtaining phaPCJ by PCR amplificationWQ；
3) phaPCJ obtained in step 2)WQThe recombinant plasmid pBBR1MCS2-phaC 'J is obtained by adopting the steps of recovering the gel through cutting, performing double enzyme digestion through HindIII and EcoRI, inserting the gel-digested expression vector pBBR1MCS2, and connecting the gel-digested expression vector pBBR1MCS 2-phaC' J through T4 ligaseWQ；
4) The recombinant plasmid pBBR1MCS 2-phaC' JWQTransforming Escherichia coli S17-1 competent cells, spreading the obtained bacterial liquid on LB plate containing Kan resistance, culturing, selecting positive clone, culturing, and extracting recombinant plasmid pBBR1MCS 2-phaC' JWQPerforming double enzyme digestion by HindIII and EcoRI, screening positive transformants, and then performing deletion of the mutant PHB by the obtained positive transformants and PHA synthase-4Co-culturing, recombinant plasmid pBBR1MCS 2-phaC' JWQTransformation into PHB-4To obtain the recombinant strain.
In the method for constructing the deletion mutant at the N-terminal of the PHA synthase, the reaction system in the step 2) is 50 μ l: ddH2O32.5μl；10×Pfu Buffer5μl；2.5mM dNTP5μl；Mg 2+4 mu l of the solution; 1 μ l of template DNA; 25 μ M primer 11 μ l; 25 μ M primer 21 μ l; 5U/. mu.l Pfu enzyme 0.5. mu.l;
in the method for constructing the deletion mutant at the N-terminal of the PHA synthase, the amplification conditions in the step 2) are as follows: pre-denaturation at 95 ℃ for 5 min; denaturation at 94 ℃ for 30 sec; annealing at 62 ℃ for 30 sec; extension at 72 ℃ for 2.5min for 25 cycles; extension at 72 ℃ for 10 min.
In the method for constructing the N-terminal deletion mutant of PHA synthase, in step 4), the culture is carried out at 37 ℃ overnight.
The recombinant strain produced by the method for constructing the PHA synthase N-terminal deletion mutant is applied to PHA production.
The invention has the beneficial effects that: by the method, the deletion of the N end of the PHA synthase is successfully constructed, the substrate specificity of the PHA synthase is changed by modifying the N end, the catalytic activity of the PHA synthase is improved, and the PHA yield is improved. Solves the problem of single PHA monomer composition. The effect on PHA synthase substrate specificity in different host bacteria after N-terminal deletion was also investigated. Has certain value in promoting the wider application of PHA.
Drawings
FIG. 1 is a schematic diagram of the construction process of pBBR1MCS 2-phaC' JWQ expression plasmid.
FIG. 2 is an agarose gel electrophoresis of plasmid pUC19-phaPCJWQ, wherein M is (1kb DNA Ladder (10000bp,8000bp,6000bp,5000bp,4000bp,3500bp,3000bp,2000bp,1000bp,750bp,500bp,250bp), 1 is (plasmid pUC19-phaPCJWQ), and 2 is (plasmid pUC 19-phaPCJWQ).
FIG. 3 is a photograph of phaC ' JWQ agarose gel electrophoresis, in which M is (1kb DNA Ladder (10000bp,8000bp,6000bp,5000bp,4000bp,3500bp,3000bp,2000bp,1000bp,750bp,500bp,250 bp);), 1 is (phaC ' JWQ PCR electrophoresis result.), and 2 is (phaC ' JWQ PCR electrophoresis result.).
FIG. 4 is a diagram of agarose gel electrophoresis of the recombinant plasmid digestion, wherein M is (1kb DNA Ladder (10000bp,8000bp,6000bp,5000bp,4000bp,3500bp,3000bp,2000bp,1000bp,750bp,500bp,250 bp);), 1 is (empty plasmid electrophoresis result), 2 is (recombinant plasmid electrophoresis result), 3 is (recombinant plasmid Hind III single digestion electrophoresis result), and 4 is (recombinant plasmid Hind III, EcoRI single digestion electrophoresis result).
FIG. 5 shows the results of Nile red fluorescent staining.
Detailed Description
A method for preparing an N-terminal deletion mutant of PHA synthase comprises the following steps:
example 1 uses alcaligenes eutrophus (r. eutropha) PHA synthase and aeromonas hydrophila WQ (a. hydrophila WQ) PHA synthase.
1. Cloning of PHA synthase Gene:
obtaining the sequence of Aeromonas hydrophila WQ (A. hydrophila WQ) from NCBI, and designing primers P1-5'-TTAAAGCTTCTAATGGAGCGCACCGCCCAG-3', P2-5 '-TTTGAATTCTCATGCGGCGTCCTCCTCT-3'. Plasmid pUC19-phaPCJ registered at NCBIWQUsing P1 and P2 as primers as a template, and carrying out PCR amplification to obtain phaPCJWQ. The amplification system is: the reaction system was 50. mu.l: ddH2O32.5μl；10×Pfu Buffer5μl；2.5mM dNTP5μl；Mg 2+4 mu l of the solution; 1 μ l of template DNA; 25 μ M primer 11 μ l; 25 μ M primer 21 μ l; 5U/. mu.l Pfu enzyme 0.5. mu.l; the amplification conditions were: pre-denaturation at 5 deg.C for 5 min; denaturation at 94 ℃ for 30 sec; annealing at 62 ℃ for 30 sec; extension at 72 ℃ for 2.5min for 25 cycles; extension at 72 ℃ for 10 min.
The size of the PCR product is basically consistent with the expected result, phaC' JWQThe size is 2186bp, as shown in FIG. 2.
2. Constructing a plasmid:
obtaining phaPCJ by PCR amplificationWQThe recombinant plasmid pBBR1MCS 2-phaC' J is obtained by adopting the steps of recovering the cutting glue, performing double enzyme digestion by HindIII and EcoRI, inserting the cut enzyme pBBR1MCS2, and performing overnight connection at 16 ℃ by using T4 ligaseWQ. The recombinant plasmid pBBR1MCS 2-phaC' JWQTransforming Escherichia coli S17-1 competent cells, spreading the bacterial liquid on LB plate containing Kan resistance, culturing at 37 deg.C overnight, selecting positive clone, culturing, and extracting recombinant plasmid pBBR1MCS 2-phaC' JWQPositive transformants were screened by double digestion with HindIII and EcoRI. Then the obtained positive transformant and PHA synthase deletion mutant PHB are subjected to-4Co-culture, transformation of recombinant plasmids into PHB-4Obtaining recombinant bacteria, and carrying out quality improvement and enzyme cutting verification.
The verification is shown in FIG. 3, and the sequencing result shows that the expression vector pBBR1MCS 2-phaC' JWQThe construction was successful.
3. And (3) verifying the function of the recombinant bacteria:
plasmid-containing R.eutropha PHB-4The recombinant bacteria are cultured in two steps, a single colony is picked by a toothpick and cultured in 10ml LB overnight, when seed liquid grows well, the bacterial colony is transferred into 100ml mineral salt culture medium, corresponding antibiotics are added, the bacterial colony is cultured for 72h at 200rpm under the condition of 30 ℃, the bacterial colony is collected by centrifugation for 10min at 8000rpm, the bacterial colony is washed once by water and once by alcohol, the bacterial colony is freeze-dried to constant weight, and 50mg of the bacterial colony is weighed and esterified for gas chromatography analysis.
In the research, the activity of PHA synthase is preliminarily and qualitatively detected by Nile red which is a fluorescent dye and can be used for dyeing lipids, proteins and the like. Preparing a solid culture medium for fermenting all mineral salt solid culture mediums into a solid plate, adding 0.5mg/ml Nile red, culturing for 3 days in a dark place, and photographing with an ultraviolet lamp to observe whether fluorescence exists or not so as to preliminarily detect the PHA synthase activity. As a result, as shown in FIG. 4, it was preliminarily confirmed that the constructed PHA synthase had PHA synthase activity by the deletion of the N-terminus.
The results of the molecular composition and content of PHA produced by the recombinant bacteria are shown in Table 1.
TABLE 1
The results are shown in Table 1 with pBBR1MCS 2-phaC' JWQThe recombinant strain of (a) is capable of producing PHA in a medium with three different carbon sources, and the R.eutropha synthase deletion mutant and the recombinant strain do not contain pBBR1MCS 2-phaC' JWQThe recombinant strain can not produce PHA, thereby proving that the expression plasmid is successfully constructed and the synthase gene has function. PHA monomers generated by three different carbon sources have different compositions, the thallus grows best when lauric acid is used as a carbon source, the PHA yield is highest and accounts for 65.05 percent of the dry weight of cells, and the generated 3HB content is 60.29 percent at most. With fructose as the carbon source, only 3HB monomer was produced, and 3HHX was not produced. And the two groups of control groups do not generate PHA, which proves that the constructed plasmids are successful and the PHA synthase gene has the function of synthesizing PHA.
Claims (5)
1. A method for constructing an N-terminal deletion mutant of PHA synthase is characterized by comprising the following steps:
1) obtaining a sequence of aeromonas hydrophila WQ (A.hydrophila WQ) from NCBI, and designing primers P1 and P2 according to the sequence;
P1-5’-TTAAAGCTTCTAATGGAGCGCACCGCCCAG-3’P2-5’-TTTGAATTCTCATGCGGCGTCCTCCTCT-3’
2) in the form of pUC19-phaPCJWQUsing P1 and P2 as primers as a template, and obtaining phaPCJ by PCR amplificationWQ；
3) phaPCJ obtained in step 2)WQThe recombinant plasmid pBBR1MCS2-phaC 'J is obtained by adopting the steps of recovering the gel through cutting, performing double enzyme digestion through HindIII and EcoRI, inserting the gel-digested expression vector pBBR1MCS2, and connecting the gel-digested expression vector pBBR1MCS 2-phaC' J through T4 ligaseWQ；
4) The recombinant plasmid pBBR1MCS 2-phaC' JWQTransforming Escherichia coli S17-1 competent cells, spreading the obtained bacterial liquid on LB plate containing Kan resistance, culturing, selecting positive clone, culturing, and extracting recombinant plasmid pBBR1MCS 2-phaC' JWQPerforming double enzyme digestion by HindIII and EcoRI, screening positive transformants, and then performing deletion of the mutant PHB by the obtained positive transformants and PHA synthase-4Co-culturing, recombinant plasmid pBBR1MCS 2-phaC' JWQTransformation into PHB-4To obtain the recombinant strain.
2. The method as claimed in claim 1, wherein the reaction system in step 2) is 50 μ l: ddH2O32.5μl；10×Pfu Buffer5μl；2.5mM dNTP5μl；Mg2+4 mu l of the solution; 1 μ l of template DNA; 25 μ M primer 11 μ l; 25 μ M primer 21 μ l; 5U/. mu.l Pfu enzyme 0.5. mu.l;
3. the method as claimed in claim 1, wherein the amplification conditions in step 2) are as follows: pre-denaturation at 95 ℃ for 5 min; denaturation at 94 ℃ for 30 sec; annealing at 62 ℃ for 30 sec; extension at 72 ℃ for 2.5min for 25 cycles; extension at 72 ℃ for 10 min.
4. The method as set forth in claim 1, wherein the cultivation in step 4) is carried out at 37 ℃ overnight.
5. The use of the recombinant bacterium produced by the method for constructing the deletion mutant of the N-terminal of PHA synthase described in claim 1 in the production of PHA.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110307034.5A CN113046287A (en) | 2021-03-23 | 2021-03-23 | Construction method and application of PHA synthase N-terminal deletion mutant |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110307034.5A CN113046287A (en) | 2021-03-23 | 2021-03-23 | Construction method and application of PHA synthase N-terminal deletion mutant |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113046287A true CN113046287A (en) | 2021-06-29 |
Family
ID=76514364
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110307034.5A Pending CN113046287A (en) | 2021-03-23 | 2021-03-23 | Construction method and application of PHA synthase N-terminal deletion mutant |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113046287A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115261346A (en) * | 2022-04-06 | 2022-11-01 | 深圳蓝晶生物科技有限公司 | Engineered microorganisms expressing acetoacetyl-coa reductase variants and methods of increasing PHA production |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101058799A (en) * | 2007-04-19 | 2007-10-24 | 清华大学 | Method of producing polyhydroxyalkanoates and special-purpose engineering bacterium for the same |
| US20070277268A1 (en) * | 2005-05-24 | 2007-11-29 | Lg Chem, Ltd. | Cells or plants producing polylactate or its copolymers and uses thereof |
| CN101696431A (en) * | 2009-10-29 | 2010-04-21 | 辽宁大学 | Method for producing copolymer PHBHHx by metabolism control of aeromonas hydrophila |
| US20110183388A1 (en) * | 2005-08-09 | 2011-07-28 | Julia Sabirova | Extracellular Polyhydroxyalkanoates Produced By Genetically Engineered Microorganisms |
| CN107151265A (en) * | 2016-03-04 | 2017-09-12 | 清华大学 | Polyhydroxyalkanoates particle associated proteins PhaP mutant and preparation method and application |
| CN111235173A (en) * | 2020-01-22 | 2020-06-05 | 清华大学 | Method for producing short-medium chain polyhydroxyalkanoate PHA and functional derivatives thereof |
| CN112368385A (en) * | 2018-06-15 | 2021-02-12 | 株式会社钟化 | Mutant polyhydroxyalkanoate synthase, gene and transformant thereof, and method for producing polyhydroxyalkanoate |
-
2021
- 2021-03-23 CN CN202110307034.5A patent/CN113046287A/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070277268A1 (en) * | 2005-05-24 | 2007-11-29 | Lg Chem, Ltd. | Cells or plants producing polylactate or its copolymers and uses thereof |
| US20110183388A1 (en) * | 2005-08-09 | 2011-07-28 | Julia Sabirova | Extracellular Polyhydroxyalkanoates Produced By Genetically Engineered Microorganisms |
| CN101058799A (en) * | 2007-04-19 | 2007-10-24 | 清华大学 | Method of producing polyhydroxyalkanoates and special-purpose engineering bacterium for the same |
| CN101696431A (en) * | 2009-10-29 | 2010-04-21 | 辽宁大学 | Method for producing copolymer PHBHHx by metabolism control of aeromonas hydrophila |
| CN107151265A (en) * | 2016-03-04 | 2017-09-12 | 清华大学 | Polyhydroxyalkanoates particle associated proteins PhaP mutant and preparation method and application |
| CN112368385A (en) * | 2018-06-15 | 2021-02-12 | 株式会社钟化 | Mutant polyhydroxyalkanoate synthase, gene and transformant thereof, and method for producing polyhydroxyalkanoate |
| CN111235173A (en) * | 2020-01-22 | 2020-06-05 | 清华大学 | Method for producing short-medium chain polyhydroxyalkanoate PHA and functional derivatives thereof |
Non-Patent Citations (2)
| Title |
|---|
| XIAOYUN LU 等: "Molecular cloning and functional analysis of two polyhydroxyalkanoate synthases from two strains of Aeromonas hydrophila spp" * |
| ZHONG ZHENG 等: "Mutation on N-terminus of polyhydroxybutyrate synthase of Ralstonia eutropha enhanced PHB accumulation" * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115261346A (en) * | 2022-04-06 | 2022-11-01 | 深圳蓝晶生物科技有限公司 | Engineered microorganisms expressing acetoacetyl-coa reductase variants and methods of increasing PHA production |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wang et al. | Polyhydroxyalkanoates, challenges and opportunities | |
| JP5550066B2 (en) | PHA synthase mutant derived from Pseudomonas species 6-19 and method for producing lactate polymer or copolymer using the same | |
| Danis et al. | Preparation of poly (3-hydroxybutyrate-co-hydroxyvalerate) films from halophilic archaea and their potential use in drug delivery | |
| KR101037354B1 (en) | Recombinant microorganism able to produce polylactate or polylactate copolymer from sucrose and method for producing polylactate or polylactate copolymer from sucrose using the same | |
| CN102307988B (en) | Recombinant relastonia eutropha capable of producing polyactic acid or polylatic acid copolymer, and method for producing polyactic acid or polylatic acid copolymer using same | |
| EP3101129B1 (en) | Microorganism having adjusted expression of r-specific enoyl-coa hydratase gene, and method for manufacturing polyhydroxyalkanoate copolymer using same | |
| CN116970659B (en) | Method for producing polyhydroxyalkanoate | |
| JP6313708B2 (en) | High molecular weight PHA producing microorganism and method for producing high molecular weight PHA using the same | |
| Esposito et al. | Enhanced production of biobased, biodegradable, Poly (3-hydroxybutyrate) using an unexplored marine bacterium Pseudohalocynthiibacter aestuariivivens, isolated from highly polluted coastal environment | |
| EP1120461B1 (en) | Process for producing copolymerized polyester | |
| CN113046287A (en) | Construction method and application of PHA synthase N-terminal deletion mutant | |
| Qi et al. | A high molecular weight polymalate is synthesized by the whole genome duplicated strain Aureobasidium melanogenum OUC | |
| Klask et al. | Heterologous expression of various PHA synthase genes in Rhodospirillum rubrum | |
| CN101525599B (en) | Enzyme relevant to synthesis of poly (hydroxybutyrate-hydroxyvalerate) and encoding gene and application thereof | |
| JP2008086238A (en) | Method for producing polyhydroxyalkanoate | |
| CN101008011A (en) | Recombinant strain for producing polyhydroxyalkanoate and its construction method and uses | |
| Peña et al. | Bioprocess design: fermentation strategies for improving the production of alginate and poly-β-hydroxyalkanoates (PHAs) by Azotobacter vinelandii | |
| JPWO2008090873A1 (en) | Process for producing polyhydroxyalkanoate | |
| CN114015668B (en) | Rhodococcus pyridine polyhydroxyalkanoate synthetase and encoding gene and application thereof | |
| JP7071283B2 (en) | Production method of polyhydroxyalkanoate and microorganisms | |
| EP2963119A1 (en) | Production method for copolymer polyhydroxyalkanoate using genetically modified strain of fatty acid -oxidation pathway | |
| JP5839854B2 (en) | Microbial culture method | |
| KR20190060584A (en) | Improved production method for poly(3-hydroxypropionate) | |
| CN115261347A (en) | Engineered microorganisms expressing acetoacetyl-CoA reductase variants and methods of increasing the proportion of 3-hydroxycaproic acid in PHA | |
| Chien et al. | Functional Expression of pha CAB Genes from Cupriavidus taiwanensis Strain 184 in Escherichia coli for Polyhydroxybutyrate Production |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210629 |